Introduction

Oral and maxillofacial cancer, particularly oral squamous cell carcinoma (OSCC), presents significant challenges in global health due to its high morbidity and mortality rates. The complexity of these cancers is compounded by late-stage diagnoses, which are often a result of limited public awareness and insufficient screening options. Traditional diagnostic methods, such as biopsies and histopathological examinations, are often slow and subjective, necessitating the development of more efficient and objective diagnostic tools. Early diagnosis and effective treatment are crucial in improving patient outcomes, as they can significantly enhance survival rates and reduce the burden of disease. In recent years, the integration of artificial intelligence (AI) and nanotechnology has emerged as a promising frontier in oncology, offering innovative solutions for the diagnosis and treatment of oral and maxillofacial cancers.This emerging convergence of AI and nanotechnology enables early detection through advanced imaging and molecular profiling, and facilitates personalized treatment strategies that improve clinical outcomes and reduce therapeutic toxicity[1].

Oral cancer remains a prevalent and aggressive malignancy with a low five-year survival rate due to delayed diagnoses and limited screening options [2, 3].Traditional diagnostic methods are often slow and subjective, leading to challenges in early detection and personalized treatment strategies [4].A comprehensive retrospective analysis of primary oral cancers in Shiraz, Iran, revealed significant clinicopathological characteristics that enhance understanding of regional disease presentation, aiding in the refinement of diagnostic and therapeutic strategies tailored to population-specific profiles[5]. The high morbidity and mortality rates associated with oral cancer highlight the need for improved diagnostic and therapeutic approaches [6].

Early detection is critical in cancer prevention and treatment, as it allows for timely intervention and improved patient management [2, 6].Effective treatment strategies are essential to reduce the side effects and unfavorable consequences associated with conventional therapies [2].Personalized treatment plans, tailored to individual patient data, can optimize outcomes and enhance the efficacy of therapeutic interventions [7].

AI has revolutionized cancer diagnosis and treatment by enabling early detection, precise characterization, and personalized treatment planning through advanced image analysis and predictive modeling [8, 9].Machine learning and deep learning algorithms facilitate the analysis of vast datasets, improving diagnostic accuracy and treatment optimization [4, 9].Nanotechnology offers innovative solutions for cancer diagnosis and therapy, utilizing nanoparticles for diagnostic probes and targeted drug delivery, thereby enhancing treatment efficacy and reducing toxicity [2, 10].The integration of AI and nanotechnology holds promise for developing personalized nanomedicines, offering more efficient and targeted cancer treatments [10].

Advances in AI for Oral and Maxillofacial Cancer Diagnosis

Advances in AI have significantly impacted the field of oral and maxillofacial cancer diagnosis, offering innovative solutions that enhance accuracy, speed, and personalization in medical diagnostics. AI technologies are being integrated into various aspects of cancer detection and management, from image analysis to real-time decision support systems. This section explores the key advancements in AI applications for oral and maxillofacial cancer diagnosis, highlighting their transformative potential.

AI technologies, particularly deep learning models like convolutional neural networks (CNNs), have been instrumental in automating the detection and characterization of lesions from medical images, thereby improving diagnostic efficacy and reducing human error [4, 11].Automated image analysis tools, such as DeepPath and OralDx, enable faster and more precise diagnosis by processing histopathological and lesion images, facilitating early detection and intervention [12].

Machine learning algorithms are employed to analyze multifaceted clinical and molecular datasets, allowing for meticulous classification and risk stratification in oral cancer diagnosis [4, 13].Predictive analytics methodologies leverage patient data to assess risk and prognosticate disease trajectory, supporting personalized treatment strategies [4].

AI is being integrated with advanced imaging modalities such as fluorescence imaging, optical coherence tomography (OCT), and Raman spectroscopy to enhance the detection and diagnosis of oral cancer [6].These integrations allow for the non-invasive analysis of samples, improving the accuracy and speed of diagnosis while minimizing patient discomfort [12].

AI-driven decision support systems provide clinicians with real-time diagnostic insights, aiding in the selection of appropriate treatment modalities and disease monitoring [4].These systems harness AI’s ability to process vast amounts of data quickly, offering timely and accurate diagnostic support that can significantly improve patient outcomes [14, 15]. Intelligent optimization algorithms have shown remarkable effectiveness in enhancing sentiment analysis by improving the accuracy and efficiency of text data classification, thereby contributing to advancements in natural language processing[16].

Nanotechnology-Enabled Diagnostic Approaches

Nanotechnology has emerged as a transformative tool in the diagnosis of oral and maxillofacial cancer, offering innovative solutions that enhance sensitivity, specificity, and non-invasiveness. This section explores the various nanotechnology-enabled diagnostic approaches that are revolutionizing the detection and management of oral cancer. These advancements are crucial for early detection, which is vital for improving patient outcomes and reducing mortality rates associated with oral cancer.

Nanotechnology has facilitated the development of highly sensitive biosensors and molecular probes that can detect specific biomarkers associated with oral cancer. These tools offer non-invasive diagnostic options that surpass traditional methods in sensitivity and specificity, enabling earlier detection of malignancies [17, 18].Advanced imaging techniques using nanoparticles provide enhanced contrast and resolution, allowing for the detailed visualization of cancerous tissues. This capability is particularly beneficial in identifying early-stage lesions that might be missed by conventional imaging methods [17, 19].

AFM, when integrated with AI, offers a powerful approach for characterizing cancer cells at the nanoscale. This combination allows for the precise analysis of cellular morphology and mechanical properties, which are critical for distinguishing cancerous cells from healthy ones[20].AI algorithms enhance the interpretative power of AFM data, providing insights into the molecular and structural changes in cancer cells. This integration facilitates the development of predictive models for cancer diagnosis and progression[20].

Nanoparticles serve as effective contrast agents in imaging modalities such as MRI and PET scans. Their unique optical properties, such as localized surface plasmon resonances, improve image clarity and enable the detection of smaller lesions [17, 21].The use of nanoparticles in imaging enhances the ability to differentiate between malignant and benign tissues, addressing a significant limitation of traditional imaging techniques[21].

Nanotechnology-based platforms are capable of detecting cancer at its earliest stages by identifying specific molecular changes. These platforms are designed to be highly sensitive and specific, reducing the likelihood of false positives and negatives[22].Nanotechnology aids in the differentiation between malignant and benign lesions, a critical factor in determining the appropriate clinical management and treatment strategies for patients[21].

AI-Driven Nanotechnology in Oral and Maxillofacial Cancer Treatment

The AI and nanotechnology is revolutionizing the treatment of oral and maxillofacial cancer by enhancing the precision and efficacy of therapeutic interventions. AI-driven nanotechnology offers innovative solutions for targeted drug delivery, personalized medicine, and combination therapies, significantly improving patient outcomes. This section explores the various facets of AI-driven nanotechnology in the context of oral and maxillofacial cancer treatment, highlighting its transformative potential. Recent research highlights the significant role of long non-coding RNAs (lncRNAs) in the pharmacological treatment of oral squamous cell carcinoma, revealing their regulatory functions in tumor growth, metastasis, and therapeutic resistance, which offer promising targets for novel treatment strategies[23].

AI algorithms are employed to design and optimize nanoparticle-based drug delivery systems, enhancing their specificity and efficacy in targeting cancer cells while minimizing systemic side effects [10, 24]. Machine learning and neural networks facilitate the customization of nanocarriers by predicting optimal configurations, such as size, surface chemistry, and drug release profiles, tailored to specific therapeutic needs [24]. AI-driven design of nanocarriers improves drug loading capacity and controlled release, ensuring precise delivery to tumor sites and reducing off-target effects [24, 25].

AI models analyze vast datasets, including omics data and clinical information, to predict patient-specific responses to nanotherapeutics, enabling personalized treatment plans [10, 26]. By leveraging AI, researchers can account for interpatient variability and tumor microenvironment dynamics, optimizing nanomedicine design for individual patients [10, 26]. AI-driven predictive modeling enhances the precision of treatment impact predictions, facilitating the development of personalized nanomedicine strategies [27].

The synergy of AI and nanotechnology supports the development of combination therapies that integrate nanomedicine with AI-guided treatment regimens, improving therapeutic outcomes [28]. AI optimizes the selection and dosage of drug combinations, enhancing the efficacy of multifunctional nanocarriers that deliver multiple therapeutic agents simultaneously [28]. Such combination therapies offer advantages like enhanced solubility, stability, and site-specificity, crucial for effective cancer treatment [28].

AI enhances the design of multifunctional nanopharmaceuticals, which can perform multiple roles, such as drug delivery and optical imaging, simultaneously[28].By predicting interactions between drugs, nanocarriers, and biological systems, AI optimizes drug combinations to achieve synergistic effects and minimize toxicity [25, 27].AI-driven optimization of nanomedicine properties accelerates the development of effective and safe treatment options, paving the way for advanced cancer therapies[25]. AI and nanotechnology synergistically enhance oral cancer treatment by enabling precision drug delivery, personalized therapy planning, and development of multifunctional nanomedicines. Table 1 summarizes the key roles of AI and nanotechnology in various treatment modalities, demonstrating their potential to improve therapeutic efficacy and reduce systemic toxicity.

Treatment responses with nanotherapeutics

The integration of AI and nanotechnology in oral and maxillofacial cancer treatment represents a significant advancement in precision medicine. This approach leverages the unique properties of nanoparticles for targeted drug delivery and the analytical power of AI to optimize treatment regimens. The combination of these technologies aims to enhance therapeutic efficacy, reduce systemic toxicity, and personalize treatment plans based on individual patient profiles. The following sections explore the various aspects of treatment responses with nanotherapeutics in this context.

AI can optimize the design and application of nanomedicines by predicting drug interactions and enhancing targetability, thereby improving therapeutic outcomes and minimizing toxicity[10]. AI-guided regimens can personalize treatment plans by analyzing complex biomarkers and patient data, leading to more effective and tailored cancer therapies[26].

AI tools utilize machine learning algorithms to refine the design of multifunctional nanoparticles, enhancing their ability to deliver drugs effectively and respond to environmental triggers[10].These AI-optimized nanopharmaceuticals can improve the pharmacokinetics and bioavailability of anticancer agents, enabling site-specific accumulation and reducing systemic side effects[29].

Nanotechnology for Treatment Enhancement

Liposomes, dendrimers, and polymeric nanoparticles are engineered for targeted drug delivery, specifically targeting oral tumors to improve drug efficacy and reduce toxicity. Smart nanocarriers are able to sense and react to biological signals such as shifts in pH or temperature enabling them to release drugs in a controlled manner and significantly increase the precision of treatment delivery [30]. Nanotechnology enhances these therapies by using light-mediated mechanisms to eradicate cancer cells with minimal damage to healthy tissues [31]. These technologies enable precision treatment delivery, potentially revolutionizing how drugs are administered and improving patient outcomes [32].

Safety, Challenges, and Regulatory Considerations

Ensuring the safety of nanomaterials is crucial, as potential toxicity and long-term interactions with biological systems remain significant concerns. The application of AI in oncology raises ethical issues, particularly regarding data privacy and the use of patient information for treatment optimization[10]. Regulatory challenges and the need for standardized guidelines are critical barriers to the widespread adoption of AI-nanomaterial combined therapies.

Although the integration of AI and nanotechnology in cancer therapy offers substantial potential, addressing the associated challenges remains imperative. Establishing the biocompatibility and safety of nanomaterials, along with managing the ethical concerns surrounding AI use, is vital to achieving successful clinical implementation. Additionally, overcoming regulatory hurdles and establishing clear guidelines will be vital for the broader implementation of these advanced therapies. As research progresses, interdisciplinary collaboration will be key to unlocking the full potential of AI and nanotechnology in revolutionizing cancer care.

Future Perspectives and Emerging Trends

The fusion of AI and nanotechnology holds immense potential to transform the diagnosis and treatment of oral and maxillofacial cancers. This integration is anticipated to drive major progress in precision medicine, fostering more personalized and effective approaches to cancer management. The following sections explore future perspectives and emerging trends in this field, focusing on the integration of AI with nanorobotics, advances in AI-powered multi-omics analysis, and the development of theranostic nanoplatforms.

AI-controlled nanorobots represent a groundbreaking approach to cancer treatment, offering precise and non-invasive tumor eradication. These nanorobots are engineered to autonomously traverse the human body, precisely targeting and eliminating malignant cells while preserving healthy tissues, thereby reducing side effects and shortening recovery periods [33]. The incorporation of advanced AI algorithms enables these nanorobots to dynamically adapt and react in real time, ensuring precise control and optimal therapeutic effectiveness. This approach marks a significant shift from traditional invasive cancer treatments, promising a more patient-centered alternative. Although currently conceptual, this technology serves as a visionary blueprint for future cancer therapies, highlighting the potential of AI and nanotechnology to transform cancer treatment and improve patient outcomes[33].

AI’s ability to analyze multi-omics data is crucial for developing personalized therapies and understanding oral tumor characteristics. Techniques such as single-cell sequencing and imaging mass cytometry enable AI to uncover insights into drug resistance and the tumor microenvironment[34]. AI algorithms such as convolutional neural networks (CNNs) and support vector machines (SVMs) have shown remarkable accuracy in detecting oral cancer from histopathological images, enabling earlier diagnosis and timely treatment interventions [35]. The integration of AI In the management of oral cancer, these advancements are transforming healthcare by enhancing diagnostic accuracy, refining staging precision, and enabling personalized treatment planning, which collectively lead to improved patient outcomes [35].

Theranostic nanoplatforms, which combine diagnostic and therapeutic functions, are being developed to enhance cancer care. These systems employ nanoparticles to achieve accurate imaging and targeted therapy, thereby reducing damage to surrounding healthy tissues [20]. AI plays a pivotal role in optimizing the design of these nanomaterials, improving their interactions with biological systems and enhancing therapeutic efficacy[26]. The synergy between AI and nanotechnology in theranostic applications promises to revolutionize cancer management by enabling more accurate diagnostics and personalized treatment strategies[20][26].Recent studies underscore significant advancements in diagnostic and therapeutic technologies for oral cancers, highlighting the integration of precision medicine and emerging tools that enhance early detection and personalized treatment plans[36]. Wearable nanosensors provide the capability for continuous monitoring of physiological biomarkers, which is crucial for early cancer detection and tracking disease progression. These sensors can detect subtle changes in biomarker levels, offering a more dynamic and responsive approach to cancer management compared to traditional methods[37, 38]. The integration of nanotechnology with AI allows for precise identification and monitoring of cancer cells. Such precision enables the design of personalized treatment strategies that address each patient’s unique needs, potentially enhancing therapeutic effectiveness while minimizing adverse effects [20]. Wearable devices enable non-invasive data collection, which enhances patient comfort and compliance. This is particularly beneficial in oral and maxillofacial cancer, where invasive procedures can be challenging and uncomfortable for patients[39].

Conclusion

The convergence of AI and nanotechnology introduces a groundbreaking strategy for diagnosing and treating oral and maxillofacial cancers. AI contributes by refining diagnostic accuracy through sophisticated imaging analysis and predictive algorithms, while nanotechnology provides precise drug delivery and combined diagnostic-therapeutic (theranostic) functions. Collectively, these innovations promote early detection, individualized therapy, and enhanced clinical outcomes. Their synergy is especially beneficial in addressing tumor heterogeneity and drug resistance, marking a significant advancement in modern cancer management.

AI-based approaches, including machine learning and deep learning, enhance diagnostic precision by processing complex medical data and imaging, enabling earlier detection and timely intervention. Nanotechnology utilizes nanoparticles for highly specific imaging and targeted drug delivery, reducing harm to healthy tissues while improving treatment effectiveness. The integration of AI and nanotechnology supports the design of individualized treatment plans that maximize therapeutic benefits and minimize adverse effects.

The integration of AI and nanotechnology in oral and maxillofacial cancer care has significant implications for improving diagnostic accuracy, treatment personalization, and patient outcomes.

AI algorithms demonstrate high accuracy in identifying cancerous tissues from histopathological images, facilitating early diagnosis and timely intervention. AI enables the creation of personalized treatment strategies that adapt therapies to each patient’s specific data, leading to enhanced survival outcomes and improved quality of life. Nanotechnology enhances drug delivery systems, allowing for targeted treatment that reduces toxicity and improves therapeutic efficacy. The use of AI in predictive modeling and risk stratification helps prioritize high-risk patients for evaluation, optimizing resource allocation and improving patient management.

The future of AI and nanotechnology in oral and maxillofacial cancer care holds promising potential for further advancements in research and clinical applications. Ongoing interdisciplinary collaboration is crucial for tackling technical, ethical, and regulatory barriers, facilitating the effective integration of AI and nanotechnology into clinical settings. Future studies should prioritize the creation of multimodal AI frameworks and the refinement of AI-assisted surgical navigation to improve precision and therapeutic outcomes in cancer management. Recent evaluations demonstrate that AI systems exhibit high accuracy and efficiency in medical diagnostics, significantly enhancing decision-making processes and optimizing patient management[40]. Clinical trials and standardization of data collection procedures are necessary to validate the efficacy and safety of AI and nanotechnology applications in cancer care. The integration of AI and nanotechnology in precision medicine will likely lead to more personalized and effective cancer treatments, moving beyond a one-size-fits-all approach. Although incorporating AI and nanotechnology into oral and maxillofacial cancer management presents significant advantages, challenges related to data integrity, clinical validation, and ethical issues persist. Coordinated collaboration among clinicians, researchers, and policymakers is vital to fully harness these technologies and advance patient care outcomes. Solitary central neurofibroma of the maxilla, though rare, represents a distinct benign peripheral nerve sheath tumor, with diagnostic challenges that highlight the importance of histopathological evaluation in maxillofacial lesions[41]. As these challenges are addressed, the integration of AI and nanotechnology is set to play a crucial role in cancer care, bringing renewed optimism to both patients and medical professionals.

Acknowledgements

The authors utilized artificial intelligence tools, notably Perplexity.ai, to enhance the manuscript’s clarity and language quality throughout the drafting stages. All AI-generated inputs and recommendations were thoroughly reviewed and refined by the authors, who bear full responsibility for the accuracy and authenticity of the final manuscript.

Conflict of Interest Statement

The authors declare that there are no conflicts of interest related to the research, authorship, or publication of this manuscript. All authors have disclosed any financial or personal relationships that could potentially influence or bias the work presented.